Schrodinger
Latest round
- Series E
Last raised
- May 2019
Total raised
- $110M
Investors
- 10
About Schrodinger
Founded in 1990 and headquartered in New York, US, Schrodinger, LLC specializes in computational software for molecular research.88 million shares.Schrödinger offers a physics-based software platform designed to facilitate molecular discovery and design across diverse sectors, particularly drug discovery and materials science. Key products include Maestro, Glide, FEP+, and LiveDesign, enabling researchers to discover and optimize molecules. These tools are essential in applications such as small molecule drug discovery, biologics development, and materials optimization for various industries.54 mn. The company is focusing on the development of new software tools aimed at addressing evolving molecular research needs. Additionally, Schrodinger plans to increase its presence in European and Asian markets by 2025, enhancing accessibility to its solutions and fostering collaborations with local research institutions.
Who invested in Schrodinger
10 investors across 2 rounds
See all investors in Schrodinger
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Schrodinger
Who invested in Schrodinger?
Schrodinger has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Schrodinger raised?
Schrodinger has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Schrodinger last raise money?
Schrodinger's most recent round on record is a Series E, in May 2019.
What does Schrodinger do?
Founded in 1990 and headquartered in New York, US, Schrodinger, LLC specializes in computational software for molecular research.
Where is Schrodinger headquartered?
Schrodinger is headquartered in New York, US.
Which VCs invest in companies like Schrodinger?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Schrodinger's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series E
Raising like Schrodinger? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.